Diabetes mellitus - risk factor for atrial fibrillation. Potential therapeutic implications

被引:0
|
作者
Meinertz, T. [1 ]
Sydow, K. [2 ]
机构
[1] Deutsch Herzstiftung, D-60322 Frankfurt, Germany
[2] Univ Herzzentrum Hamburg, Hamburg, Germany
关键词
Metabolic disorder; Glycemic control; Cardiac arrhythmia; Cardiovascular events; Prognosis; METABOLIC SYNDROME; PREVALENCE; OBESITY; COHORT; ADULTS; IMPACT;
D O I
10.1007/s00059-014-4085-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between atrial fibrillation and diabetes mellitus type 2 is controversial, and various studies have demonstrated conflicting results. However, the majority of larger prospective studies published during recent years demonstrated a positive correlation. After multivariate adjustment diabetes increased the risk for atrial fibrillation at least two fold. This combination is associated with substantially increased risks of death and cardiovascular events (stroke and heart failure). Atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy.
引用
收藏
页码:320 / 324
页数:5
相关论文
共 50 条
  • [1] Diabetes mellitus is a risk factor for new-onset atrial fibrillation
    Dublin, Sascha
    Glazer, Nicole L.
    Smith, Nicholas L.
    Psaty, Bruce M.
    Lumley, Thomas
    Wiggins, Kerri L.
    Page, Richard L.
    Heckbert, Susan R.
    CIRCULATION, 2007, 115 (08) : E227 - E227
  • [2] Diabetes and palpitations are risk factors of atrial fibrillation. The Tromso study
    Nyrnes, A.
    Arnesen, E.
    Njolstad, I.
    Mathiesen, E. B.
    Wilsgaard, T.
    Lochen, M. L.
    EUROPEAN HEART JOURNAL, 2009, 30 : 961 - 961
  • [3] Diabetes mellitus – Risikofaktor für VorhofflimmernPotenzielle therapeutische ImplikationenDiabetes mellitus – risk factor for atrial fibrillationPotential therapeutic implications
    T. Meinertz
    K. Sydow
    Herz, 2014, 39 (3) : 320 - 324
  • [4] Diabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese population
    Sun, Guozhe
    Ma, Mingfeng
    Ye, Ning
    Wang, Jun
    Chen, Yintao
    Dai, Dongxue
    Sun, Yingxian
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (05) : 791 - 796
  • [5] Factor v leiden mutation and risk of stroke in atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Chang, Y
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 530 - 530
  • [6] Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
    Lin, Yubi
    Li, Hairui
    Lan, Xianwu
    Chen, Xianghui
    Zhang, Aidong
    Li, Zicheng
    SCIENTIFIC WORLD JOURNAL, 2013,
  • [7] Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation
    Sascha Dublin
    Nicole L. Glazer
    Nicholas L. Smith
    Bruce M. Psaty
    Thomas Lumley
    Kerri L. Wiggins
    Richard L. Page
    Susan R. Heckbert
    Journal of General Internal Medicine, 2010, 25 : 853 - 858
  • [8] ATRIAL FIBRILLATION AND DIABETES MELLITUS: MANAGING THE RISK OF THROMBOEMBOLISM
    Obrezan, A. G.
    Kulikov, N., V
    KARDIOLOGIYA, 2020, 60 (07) : 108 - 114
  • [9] Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation
    Dublin, Sascha
    Glazer, Nicole L.
    Smith, Nicholas L.
    Psaty, Bruce M.
    Lumley, Thomas
    Wiggins, Kerri L.
    Page, Richard L.
    Heckbert, Susan R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 (08) : 853 - 858
  • [10] Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
    Gawalko, Monika
    Agbaedeng, Thomas A.
    Saljic, Arnela
    Mueller, Dominik N.
    Wilck, Nicola
    Schnabel, Renate
    Penders, John
    Rienstra, Michiel
    van Gelder, Isabelle
    Jespersen, Thomas
    Schotten, Ulrich
    Crijns, Harry J. G. M.
    Kalman, Jonathan M.
    Sanders, Prashanthan
    Nattel, Stanley
    Dobrev, Dobromir
    Linz, Dominik
    CARDIOVASCULAR RESEARCH, 2022, 118 (11) : 2415 - 2427